Sanara

Vensana℠ is actively investing in development and commercial stage companies across the medtech sector, including medical devices, diagnostics and data science, drug delivery, digital health, life science tools, and tech-enabled services. WHAT PARTNERSHIP MEANS TO US Vensana℠ places the highest value on partnering with experienced, insightful, and bold management teams. We hope to invest where our capital and commitment amplifies their success.

Santé is a leading early-stage venture capital firm founded in 2006, with offices in Austin and Boston. We invest at the intersection of science and technology, catalyzing disruptive opportunities across Biotech, MedTech and HealthTech. Combining extensive healthcare industry experience with deep scientific and technical expertise, we pursue innovative new opportunities to improve lives and generate returns. At Santé, we fuel entrepreneurs and form next-generation companies which shape the future of patient care, delivering better healthcare outcomes at a lower total cost to the system. Our expertise spans cellular biology, pharmaceutical drug development, device design and engineering, physician and hospital leadership, and public policy. Our investment philosophy of disciplined fund size, significant ownership positions, and diversified life sciences exposure has proven successful, as our funds have consistently generated top quartile returns for our investors. The firm has nearly $1BN under management and is investing out of Santé Health Ventures IV (a 2021 vintage fund) which follows the same successful investment strategy as our prior funds.

Cathay Health is dedicated to investing in companies at the convergence of life sciences, healthcare and technology with positive impact on human health. With a reach spanning key bio and tech hubs around the globe, we help companies scale across borders and access new markets, partners and patients. Our Strategy We back venture- and growth-stage companies with emerging technologies that catalyze groundbreaking advances in healthcare. We fund future leaders in tech-enabled medicine with differentiated approaches and strong intellectual property to personalize care, improve access and lower cost. We invest in Series A to C rounds with the ability to lead or co-invest, and help companies scale across borders. Our Focus AreasLife Science Tools Diagnostics Clinical Trial Innovation New Care Models Novel Devices & Materials Enabling Technologies For Advanced Therapies Why Cathay HealthA global platform catalyzing cross-industry collaboration: Cathay Health is affiliated to Cathay Capital – a global investment platform connecting partners and catalyzing collaborations across Europe, North America and Asia to solve the world’s most pressing challenges. Scaling companies to transform health across borders: Our global network and operating expertise across regions allows us to grow impactful companies that serve patients worldwide. Deep expertise in both healthcare and technology: Our unique expertise allows us to identify investment opportunities with the largest impact on human health and care. Investing & operating at the convergence Our team not only invests – but brings operating experience – at the convergence of life sciences, healthcare and tech. Our expertise uniquely bridges these complementary fields to maximize the potential of our portfolio companies.

As a Venture Capital Management firm founded in 2008, we've honed our expertise in Health Technologies: biotech, medical devices and digital health. Founded in 2008 by our seasoned, multi-disciplinary executive team and headquartered in Madrid and Barcelona, we are best positioned to reach most vibrant innovation hubs across Europe. We are at the intersection between… Science and Technology: We harness the power of scientific research and technological innovation to advance healthcare. Ventures and Innovation: We back visionary entrepreneurs and innovative ventures that are transforming the healthcare landscape. Digital and Healthcare: Embracing new digital technologies to enhance people's health.

Our portfolio includes companies at all stages of development, from early-stage companies testing transformative technologies to commercial-stage companies seeking additional growth. With a focus on areas with significant unmet need, Vertex seeks to build great companies that improve the health and quality of human life. We take an active role in our portfolio companies and work with exceptional entrepreneurs, industry partners and fellow venture investors to create value. Our global investment professionals bring deep scientific, medical and business knowledge to every investment we make. In an increasingly globalized economy, Vertex Ventures HC offers global expertise to companies around the world. With offices in Silicon Valley and Singapore, our investment team scouts and invests in promising companies in the U.S., Asia and beyond. Our team, along with our network of scientific advisors and venture partners, has deep local networks and capabilities in both emerging and established markets. Our agile structure means we can act quickly on investment opportunities.

DaVita Venture Group is committed to building partnerships with health care innovators to help improve the lives of patients with kidney disease and related conditions. Together, we believe we can transform the future of patient care for the better. Our Strategy We aim to invest in, acquire, and co-develop products, solutions and businesses that improve care for patients with kidney disease and related conditions. PrioritiesCare Delivery Models: Advancements to expand access to care and improve clinical outcomes through adoption of tech-enabled services, home treatments and value-based care Life Sciences: Pharmaceuticals, medical devices and diagnostics that can improve clinical outcomes and patient experience while reducing costs Digital Health: Products and services that leverage technology, data and connectivity to improve care delivery